AMBIEN CR

LOE Approaching

zolpidem tartrate

NDAORALTABLET, EXTENDED RELEASE
Approved
Sep 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

short-term treatment of insomnia through binding to the benzodiazepine site of α1 subunit containing GABA A receptors, increasing the frequency of chloride channel opening resulting in the inhibition of neuronal excitation.

Indications (1)

Clinical Trials (5)

NCT00296179Phase 4Completed

Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro

Started Feb 2006
372 enrolled
Insomnia
NCT00296790Phase 4Completed

Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)

Started Feb 2006
372 enrolled
Insomnia
NCT00283790Phase 4Completed

Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo

Started Jan 2006
36 enrolled
Insomnia
NCT00833937Phase 1Completed

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

Started Mar 2002
24 enrolled
Healthy
NCT00833521Phase 1Completed

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

Started Feb 2002
38 enrolled
Healthy